Paul Hessler
The University of Texas MD Anderson Cancer Center(US)AbbVie (United States)(US)Abbott Fund(US)
Publications by Year
Research Areas
Protein Degradation and Inhibitors, Multiple Myeloma Research and Treatments, Cancer-related gene regulation, MicroRNA in disease regulation, Ubiquitin and proteasome pathways
Most-Cited Works
- → Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours(2017)825 cited
- → Selective inhibition of the BD2 bromodomain of BET proteins in prostate cancer(2020)393 cited
- → Protein tyrosine phosphatase 1B negatively regulates leptin signaling in a hypothalamic cell line(2002)186 cited
- → Potential mechanisms of resistance to venetoclax and strategies to circumvent it(2017)186 cited
- → MCL-1 Is a Key Determinant of Breast Cancer Cell Survival: Validation of MCL-1 Dependency Utilizing a Highly Selective Small Molecule Inhibitor(2015)120 cited
- → Several Theorems in Time-Dependent Density Functional Theory(1999)87 cited